GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Resources (Shanghai) Co Ltd (SZSE:301230) » Definitions » PEG Ratio

Pharma Resources (Shanghai) Co (SZSE:301230) PEG Ratio : 5.27 (As of Jun. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Pharma Resources (Shanghai) Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Pharma Resources (Shanghai) Co's PE Ratio without NRI is 110.24. Pharma Resources (Shanghai) Co's 5-Year EBITDA growth rate is 20.90%. Therefore, Pharma Resources (Shanghai) Co's PEG Ratio for today is 5.27.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Pharma Resources (Shanghai) Co's PEG Ratio or its related term are showing as below:

SZSE:301230' s PEG Ratio Range Over the Past 10 Years
Min: 1.1   Med: 2.98   Max: 5.81
Current: 5.27


During the past 7 years, Pharma Resources (Shanghai) Co's highest PEG Ratio was 5.81. The lowest was 1.10. And the median was 2.98.


SZSE:301230's PEG Ratio is ranked worse than
83.19% of 113 companies
in the Biotechnology industry
Industry Median: 1.57 vs SZSE:301230: 5.27

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Pharma Resources (Shanghai) Co PEG Ratio Historical Data

The historical data trend for Pharma Resources (Shanghai) Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Resources (Shanghai) Co PEG Ratio Chart

Pharma Resources (Shanghai) Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial - - - 1.26 6.33

Pharma Resources (Shanghai) Co Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 6.33 -

Competitive Comparison of Pharma Resources (Shanghai) Co's PEG Ratio

For the Biotechnology subindustry, Pharma Resources (Shanghai) Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Resources (Shanghai) Co's PEG Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Resources (Shanghai) Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Pharma Resources (Shanghai) Co's PEG Ratio falls into.



Pharma Resources (Shanghai) Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Pharma Resources (Shanghai) Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=110.2427184466/20.90
=5.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Pharma Resources (Shanghai) Co  (SZSE:301230) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Pharma Resources (Shanghai) Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Pharma Resources (Shanghai) Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Resources (Shanghai) Co (SZSE:301230) Business Description

Traded in Other Exchanges
N/A
Address
No. 315, Qingda Road, Building 23, Pudong New Area, Shanghai, CHN, 201201
Pharma Resources (Shanghai) Co Ltd is engaged in the drug discovery, research and development of pharmaceutical processes, and commercial production of API intermediates.

Pharma Resources (Shanghai) Co (SZSE:301230) Headlines

No Headlines